1. Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance


    Sha Zhang et al, 2020, OncoTargets and Therapy CrossRef
  2. Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53‐dependent manner
    Bin Zhang et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
  3. Silencing RRM2 inhibits multiple myeloma by�targeting the Wnt/β‑catenin signaling pathway
    Xia Liu et al, 2019, Molecular Medicine Reports CrossRef
  4. Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2
    Yoichi Osako et al, 2019, International Journal of Oncology CrossRef
  5. Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods
    Meiqi Lu et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef
  6. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value
    Yangmei Zhou et al, 2019, BioMed Research International CrossRef
  7. siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
    Shuquan Zheng et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
  8. Downregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cells
    Nan Wang et al, 2018, Oncology Letters CrossRef